AGILE THERAPEUTICS INC Warrant Agreements
38 Contracts & Agreements
- Form of Placement Agent Warrant (Filed With SEC on February 23, 2024)
- Form of New Warrant (Filed With SEC on February 23, 2024)
- Form of New Warrant (Filed With SEC on February 23, 2024)
- Form of Placement Agent Warrant (Filed With SEC on December 20, 2023)
- Form of Series F Pre-Funded Warrant (Filed With SEC on December 20, 2023)
- Form of Series E-2 Warrant (Filed With SEC on December 20, 2023)
- Form of Series E-1 Warrant (Filed With SEC on December 20, 2023)
- Form of Warrant Amendment and Additional Issuance Agreement (Filed With SEC on December 4, 2023)
- Form of New Warrant (Filed With SEC on December 4, 2023)
- Form of Warrant Amendment Agreement, dated May 22, 2023, by and between Agile Therapeutics, Inc. and certain holders (Filed With SEC on May 25, 2023)
- Form of Amended and Restated Series B Common Stock Purchase Warrant between Agile Therapeutics, Inc. and an institutional investor, dated March 14, 2022 (Filed With SEC on May 25, 2023)
- Form of Amended and Restated Series A-2 Common Stock Purchase Warrant between Agile Therapeutics, Inc. and an institutional investor, dated July 6, 2022 (Filed With SEC on May 25, 2023)
- Form of Amended and Restated Series A-1 Common Stock Purchase Warrant between Agile Therapeutics, Inc. and an institutional investor, dated July 6, 2022 (Filed With SEC on May 25, 2023)
- Form of Amended and Restated Series A Common Stock Purchase Warrant between Agile Therapeutics, Inc. and an institutional investor, dated April 25, 2022 (Filed With SEC on May 25, 2023)
- Form of Amended and Restated Series A Common Stock Purchase Warrant between Agile Therapeutics, Inc. and an institutional investor, dated March 14, 2022 (Filed With SEC on May 25, 2023)
- Form of Amended and Restated Common Stock Purchase Warrant between Agile Therapeutics, Inc. and an institutional investor, dated October 8, 2021 (Filed With SEC on May 25, 2023)
- Form of Placement Agent warrant (Filed With SEC on May 25, 2023)
- Form of Series D Pre-funded warrant (Filed With SEC on May 25, 2023)
- Form of Series C-2 warrant (Filed With SEC on May 25, 2023)
- Form of Series C-1 warrant (Filed With SEC on May 25, 2023)
- Form of Placement Agent Warrant (Filed With SEC on May 19, 2023)
- Form of Series D Pre-Funded Warrant (Filed With SEC on May 19, 2023)
- Form of Series C-2 Warrant (Filed With SEC on May 19, 2023)
- Form of Series C-1 Warrant (Filed With SEC on May 19, 2023)
- Form of Placement Agent warrant (Filed With SEC on July 8, 2022)
- Form of Series B Pre-funded warrant (Filed With SEC on July 8, 2022)
- Form of Series A-2 warrant (Filed With SEC on July 8, 2022)
- Form of Series A-1 warrant (Filed With SEC on July 8, 2022)
- Form of Placement Agent Warrant (Filed With SEC on June 29, 2022)
- Form of Series B Pre-Funded Warrant (Filed With SEC on June 29, 2022)
- Form of Series A-2 Warrant (Filed With SEC on June 29, 2022)
- Form of Series A-1 Warrant (Filed With SEC on June 29, 2022)
- Form of Placement Agent Warrant (Filed With SEC on March 15, 2022)
- Form of Series B Warrant (Filed With SEC on March 15, 2022)
- Form of Series A Warrant (Filed With SEC on March 15, 2022)
- Form of Warrant (Filed With SEC on October 8, 2021)
- WARRANT AGREEMENT To Purchase Shares of the Common Stock of AGILE THERAPEUTICS, INC. Dated as of February 24, 2015 (the Effective Date) (Filed With SEC on February 24, 2015)
- WARRANT TO PURCHASE STOCK (Filed With SEC on April 17, 2014)
